{"id":1165,"date":"2009-06-29T15:43:11","date_gmt":"2009-06-29T19:43:11","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/busm-pathology\/?page_id=1165"},"modified":"2019-12-13T10:38:08","modified_gmt":"2019-12-13T15:38:08","slug":"dehua-wang-md","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/busm-pathology\/resident-profiles__trashed\/dehua-wang-md\/","title":{"rendered":"Dehua Wang, MD MSc"},"content":{"rendered":"<p><a href=\"\/busm-pathology\/files\/2009\/06\/dehua-wang.jpg\"><img loading=\"lazy\" width=\"201\" height=\"195\" class=\"alignnone size-medium wp-image-1166\" alt=\"dehua-wang\" src=\"\/busm-pathology\/files\/2009\/06\/dehua-wang.jpg\" \/><\/a><\/p>\n<h3>EDUCATION\/TRAINING<\/h3>\n<p style=\"padding-left: 30px;\"><strong><br \/>\nResidency: <\/strong><br \/>\nBoston University Medical Center, Department of Pathology\u00a0 July, 2009-June 2012<br \/>\nDrexel University College of Medicine, Department of Pathology, PGY1\u00a0 2008-2009<\/p>\n<p style=\"padding-left: 30px;\"><strong>Postdoctoral training:<\/strong><strong><br \/>\n<\/strong>Johns Hopkins Medical Institute, Department of Oncology\u00a0\u00a0\u00a0 2003-2008<br \/>\nUniversity of Minnesota, Department of Pathology &amp; Laboratory Medicine\u00a0\u00a0 2000-2003<\/p>\n<p style=\"padding-left: 30px;\"><strong>Graduate School:<\/strong><br \/>\nMSc, Beijing Medical University, Department of Pathology, Beijing, China\u00a0\u00a0\u00a0 1993-1996<\/p>\n<p style=\"padding-left: 30px;\"><strong>Medical School: <\/strong><br \/>\nMD, Yunyang Medical College, Shiyan, China 1984-1989<\/p>\n<h3>SPECIALITY<\/h3>\n<p style=\"padding-left: 30px;\">AP\/CP<\/p>\n<h3>SELECTED PUBLICATIONS<\/h3>\n<ol>\n<li>Dehua Wang, Ido Paz-Priel, and Alan D. Friedman\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NF-\uf06b B p50 Regulates C\/EBP\uf061 Expression and Inflammatory Cytokine-Induced Neutrophil Production\u00a0\u00a0\u00a0\u00a0 J Immunol. 2009; 182: 5757-5762<\/li>\n<li>Yeamans C, Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman AD.\u00a0\u00a0\u00a0\u00a0 C\/EBP\uf061 binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 110 (9): 3136-3142, 2007<\/li>\n<li>Cai DH,* Wang D,* Keefer J, Yeamans C, Hensley K, and Friedman AD.\u00a0\u00a0\u00a0\u00a0 C\/EBP\uf061:AP-1 Leucine Zipper Heterodimers Bind Novel DNA Elements, Activate the PU.1 Promoter, and Direct Monocyte Lineage Commitment More Potently Than C\/EBP\uf061 Homodimers or AP-1\u00a0\u00a0 *these authors contributed equally Oncogene 2007, 1-8<\/li>\n<li>Wang D, D&#8217;Costa J, Civin CI, and Friedman AD. C\/EBP\u00a0 directs monocytic commitment of primary myeloid progenitors\u00a0\u00a0 Blood\u00a0 108(4): 1223 \u2013 1229, 2006<\/li>\n<li>Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A.\u00a0 Autophagy delays apoptotic death in breast cancer cells following DNA damage\u00a0\u00a0 Cell Death and Differentiation 14(3):500-510, 2006<\/li>\n<li>Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD\u00a0 C\/EBP\uf061 and C\/EBP\uf061 myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-\uf06bB p50.\u00a0\u00a0 Mol. Cancer Res. 3 (10): 585-596, 2005<\/li>\n<li>Wang D, McDonnell MA, Kelekar A.\u00a0\u00a0 Multi-probe RPA template sets to study RNA modulation and transcriptional control of BH3-only members of the Bcl-2 family\u00a0\u00a0 Cancer Detection and Prevention 29(2), 189-200, 2005<\/li>\n<li>McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A.\u00a0\u00a0 Caspase-9 is activated in a cytochrome c-independent manner early during TNF\u03b1-induced apoptosis in murine cells\u00a0\u00a0\u00a0 Cell Death and Differentiation 10(9): 1005 \u2013 1015, 2003<\/li>\n<li>Wang D, Liao S, Gao Z\u00a0\u00a0 The study on the correlation of the labeling rate of Ki-67 antigen and the prognosis in non-small cell lung cancer.\u00a0 Chinese Journal of Clinical Oncology\u00a0\u00a0\u00a0\u00a0 26(4): 309-310, 1999<\/li>\n<li>Wang D, Liao S, Gao Z et al.\u00a0 The Prognostic significance of p53 protein expression and gene mutation in non-small cell lung cancer.\u00a0 Journal of Practical Oncology\u00a0\u00a0 13(6): 330-333, 1998<\/li>\n<li>Wang D, Zhang H, Liao S et al.\u00a0\u00a0 Study of the concordance of immunohistochemistry and PCR-SSCP detecting p53 gene abnormality.\u00a0\u00a0 Chinese Journal of Clinical and Experimental Pathology\u00a0 14(4): 350-352, 1998<\/li>\n<li>Wang D, Liao S, Gao Z et al.\u00a0\u00a0 Relationship of blood vessel and lymphatic vessel invasion to prognosis of non-small cell lung cancer in stage I and II.\u00a0\u00a0\u00a0 Cancer Research on Prevention and Treatment\u00a0\u00a0 25(4): 267-269 1998<\/li>\n<li>Wang D, Liao S, Gao Z et al.\u00a0 Study on the relationship of tumor neovascularization count to biological behavior and prognosis of non-small cell lung cancer. Chinese Journal of Clinical and Experimental Pathology 13(4): 308-310, 1997<\/li>\n<li>Wang D, Liao S, Gao Z et al.\u00a0 Multivariate analysis of prognostic factors in non-small cell lung cancer.\u00a0 National Medical Journal of China 77(7): 497-500, 1997<\/li>\n<li>Wang D, Liao S\u00a0\u00a0 Metastasis related factors and prognosis of lung cancer. A review.\u00a0 Foreign Medical Sciences (Pathophysiology and Clinical Medicine) 17 (3): 203-6, 1997<\/li>\n<\/ol>\n<h3>CONTACT INFO<\/h3>\n<p style=\"padding-left: 30px;\">Dehua.wang@bmc.org<\/p>\n<h3>PERSONAL COMMENTS REGARDING THE PROGRAM<\/h3>\n<p style=\"text-align: center; padding-left: 60px;\"><em>Since arriving here, everyone I\u2019ve met is very friendly and eager to help. I\u2019m happy to become part of this program since I desire working with an excellent group of faculty and residents in a great learning environment. Hopefully I\u2019ll also be able to take advantage one of Boston\u2019s popular offerings, seafood, especially lobster!<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EDUCATION\/TRAINING Residency: Boston University Medical Center, Department of Pathology\u00a0 July, 2009-June 2012 Drexel University College of Medicine, Department of Pathology, PGY1\u00a0 2008-2009 Postdoctoral training: Johns Hopkins Medical Institute, Department of Oncology\u00a0\u00a0\u00a0 2003-2008 University of Minnesota, Department of Pathology &amp; Laboratory Medicine\u00a0\u00a0 2000-2003 Graduate School: MSc, Beijing Medical University, Department of Pathology, Beijing, China\u00a0\u00a0\u00a0 1993-1996 Medical [&hellip;]<\/p>\n","protected":false},"author":1131,"featured_media":0,"parent":810,"menu_order":6,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1165"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/users\/1131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/comments?post=1165"}],"version-history":[{"count":9,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1165\/revisions"}],"predecessor-version":[{"id":15814,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1165\/revisions\/15814"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/810"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/media?parent=1165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}